Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19
Condition(s):Sars-CoV2; COVID-19Last Updated:February 1, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Sars-CoV2; COVID-19Last Updated:February 1, 2021Unknown status
Condition(s):Type 2 Diabetes MellitusLast Updated:January 26, 2023Completed
Condition(s):Diabetes; Diabetes Type 2; Diabetes Mellitus, Type 2; Glucose Metabolism Disorders; Metabolic Disease; Endocrine System Diseases; Diabetes MellitusLast Updated:December 26, 2023Active, not recruiting
Condition(s):Obesity; Hypertension; Hypercholesterolemia; HyperglycemiaLast Updated:January 18, 2017Completed
Condition(s):AsthmaLast Updated:May 20, 2015Terminated
Condition(s):Postpartum Hemorrhage; TwinLast Updated:July 6, 2023Completed
Condition(s):Anesthesia; Bariatric SurgeryLast Updated:December 23, 2019Completed
Condition(s):Diabetes, GestationalLast Updated:March 16, 2023Completed
Condition(s):PregnancyLast Updated:October 1, 2019Completed
Condition(s):Short Bowel SyndromeLast Updated:May 30, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.